Related Experiment Video
Updated: Aug 4, 2025
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Special Population: Lean Nonalcoholic Fatty Liver Disease
Ajay Duseja1, Arka De1, Vincent Wong2
1Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Nonalcoholic fatty liver disease (NAFLD) affects normal-weight individuals, termed lean NAFLD. Despite milder disease, some patients develop advanced liver issues, necessitating further research into optimal treatments.
Area of Science:
- Hepatology
- Metabolic Disorders
- Genetics
Background:
- Nonalcoholic fatty liver disease (NAFLD) is commonly linked to obesity.
- However, 10-20% of NAFLD patients present with a normal body mass index, a condition known as lean NAFLD.
- Lean NAFLD patients may still progress to severe liver conditions like steatohepatitis and advanced fibrosis.
Purpose of the Study:
- To highlight the existence and clinical significance of lean NAFLD.
- To discuss the contributing factors, including genetics and environment.
- To evaluate the role of noninvasive tests in diagnosing lean NAFLD.
Main Methods:
- Review of existing literature on NAFLD and lean NAFLD.
- Analysis of diagnostic accuracy of noninvasive tests for lean NAFLD.
- Discussion of genetic and environmental factors in NAFLD pathogenesis.
Main Results:
- Lean NAFLD represents a significant subset of NAFLD patients.
- Noninvasive tests demonstrate comparable accuracy to traditional assessments for lean NAFLD.
- Genetic and environmental influences are crucial in NAFLD development.
Conclusions:
- Lean NAFLD is a distinct clinical entity requiring specific consideration.
- Noninvasive diagnostic approaches are effective for lean NAFLD.
- Further research is essential to establish tailored treatment strategies for lean NAFLD patients.
More Related Videos
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:30Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...